The 20 Best Hypothalamic Tumor Doctors near Baltimore, MD

Roberto Salvatori is an Endocrinologist in Baltimore, Maryland. Dr. Salvatori is rated as an Elite provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Growth Hormone Deficiency (GHD), Hypopituitarism, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT).

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as a Distinguished provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Awake Craniotomy, and Craniectomy.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Dr. Debraj “Raj” Mukherjee’s clinical focus is the treatment of patients with primary and metastatic brain lesions. His clinical work and research emphasize the development of individual treatment plans that optimize survival and quality of life in all patients. After receiving his medical degree from Dartmouth Medical School, Dr. Mukherjee was recruited to Johns Hopkins, where he studied epidemiology, biostatistics and clinical design at the Johns Hopkins Bloomberg School of Public Health and served as Director of the Neuro-Oncology Surgical Outcomes Laboratory in the Department of Neurosurgery. Dr. Mukherjee completed neurosurgery residency at Cedars-Sinai Medical Center, where he was named a Robert Wood Johnson Foundation Health & Society Scholar. He completed an open and endoscopic skull base fellowship with the Center for Skull Base Surgery at University of Pittsburgh Medical Center, where he was a Copeland Scholar. Throughout his career, Dr. Mukherjee has led patient-centered research pursuits in neuro-oncology including development of a national registry for patients with brain tumors, creation of disease-specific quality of life instruments for patients with skull base tumors, and development of innovative clinical trials in neuro-oncology. He leads the Meningioma, Brain Metastasis, and Neurosurgical Oncology centers at Johns Hopkins Medicine, and he serves as Assistant Residency Program Director for one of the largest neurosurgical training programs in the country. His work has been supported by the American Medical Association, Glioblastoma Foundation, National Institute on Aging, and National Cancer Institute. Dr. Mukherjee can be contacted at drraj@jhmi.edu. Dr. Mukherjee is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Tumor, Awake Craniotomy, and Craniectomy.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.

Henry Brem is a Neurosurgery provider in Baltimore, Maryland. Dr. Brem is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Gliosarcoma, Glioma, Gliomatosis Cerebri, Osteotomy, and Posterior Fossa Decompression.

Dr. Jon Weingart focuses on the surgical treatment of brain tumors including benign and malignant tumors. Dr. Weingart also specializes in spinal disorders, such as cervical and lumbar disc disease, as well as other congenital and developmental abnormalities such as tethered spinal cord, spina bifida and chiari malformation. Dr. Weingart is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Osteotomy.

Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Hydrocephalus, Chiari Malformation, Chiari Malformation Type 2, Posterior Fossa Decompression, and Endoscopy.

Dr. Gary Wand is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in psychiatry and behavioral sciences. His areas of clinical expertise include endocrinology, neuroendocrine disorders and pituitary disorders. Dr. Wand serves as the director of the fellowship program and the director of the endocrine training program at the Johns Hopkins School of Medicine. Dr. Wand earned his M.D. and completed his residency at the George Washington University School of Medicine. He performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include the neurobiology of substance abuse and the physiogenetics of the stress response. Dr. Wand has been recognized in “Best Doctors in America” and is a recipient of the National Institutes of Health Merit Award. Dr. Wand is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Pituitary Tumor, Prolactinoma, Cushing's syndrome, and Hypopituitarism.

William Simonds is an Endocrinologist in Baltimore, Maryland. Dr. Simonds is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy.

Jordina Rincon-Torroella is a fellowship-trained neurosurgeon specializing in the surgical treatment of benign and malignant tumors of the brain and skull base, such as meningiomas, gliomas, pituitary tumors and metastatic brain tumors, to name a few. Dr. Rincon-Torroella earned her medical degree from the University of Barcelona medical school. She completed a postdoctoral fellowship in neurosurgical oncology at Johns Hopkins University, where she remained for residency training in neurosurgery. She completed an additional postdoctoral fellowship in cancer research and drug development at Johns Hopkins in the Ludwig Center under the mentorship of neurosurgeon Chetan Bettegowda and molecular biologist and geneticist Bert Vogelstein. Active in clinical research since 2010, Dr. Rincon-Torroella has published numerous research papers. She is also a peer reviewer for several journals and has edited two books, most recently The Neurosurgical Consult Book. Dr. Rincon-Torroella is fluent in Catalan, English and Spanish. Dr. Torroella is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Subependymoma, Ependymoma, Brain Tumor, Laminectomy, and Craniectomy.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Lina Melhem is an Endocrinologist in Baltimore, Maryland. Dr. Melhem is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Juvenile Primary Osteoporosis, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Hypothyroidism.

Hilary Whitlatch is an Endocrinologist in Baltimore, Maryland. Dr. Whitlatch is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Rabson-Mendenhall Syndrome, Hyperparathyroidism, Osteoporosis, and Postmenopausal Osteoporosis.

Kristi Silver is an Endocrinologist in Baltimore, Maryland. Dr. Silver is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Type 2 Diabetes (T2D), Thyroid Storm, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Marjorie Pennant is an Endocrinologist in Baltimore, Maryland. Dr. Pennant is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Storm, and Hyperthyroidism.

Rana Malek is an Endocrinologist in Baltimore, Maryland. Dr. Malek is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Type 2 Diabetes (T2D), Addison's Disease, Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroidectomy.

Elizabeth Lamos is an Endocrinologist in Baltimore, Maryland. Dr. Lamos is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Tumor. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Storm, and Type 1 Diabetes (T1D).